CERO
CERo Therapeutics
CERO
CERO
Delisted
CERO was delisted on the 30th of October, 2025.
45 hedge funds and large institutions have $101M invested in CERo Therapeutics in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
67% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 30
Holders
45
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$5.57M | |
| 2 | +$2.35M | |
| 3 | +$1.54M | |
| 4 |
ETH
Exos TFP Holdings
New York
|
+$1.29M |
| 5 |
DCM
Difesa Capital Management
New York
|
+$1.29M |
Top Sellers
| 1 | -$11M | |
| 2 | -$8.58M | |
| 3 | -$7.55M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$6.68M |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$4.52M |